As of September 2024, Marksans Pharma has a market cap of $1.33B. This makes Marksans Pharma the world's 6303th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $801.83M | 0.56% |
2023 | $797.38M | 176.57% |
2022 | $288.31M | -3.16% |
2021 | $297.72M | -0.82% |
2020 | $300.19M | 263.17% |
2019 | $82.66M | -40.04% |
2018 | $137.85M | -30.29% |
2017 | $197.74M | 0.25% |
2016 | $197.24M | -61.94% |
2015 | $518.22M | 70.38% |
2014 | $304.15M | 249.15% |
2013 | $87.11M | 417.65% |
2012 | $16.83M | 100.00% |
2011 | $8.41M | -54.05% |
2010 | $18.31M | -35.09% |
2009 | $28.21M | -21.92% |
2008 | $36.13M | -76.51% |
2007 | $153.81M | 188.13% |
2006 | $53.38M | -48.66% |
2005 | $103.97M | 15.35% |
2004 | $90.13M | 247.19% |
2003 | $25.96M | 118.54% |
2002 | $11.88M | - |